Drug-Induced Gingival Overgrowth-Molecular Aspects of Drug Actions

被引:14
|
作者
Drozdzik, Agnieszka [1 ]
Drozdzik, Marek [2 ]
机构
[1] Pomeranian Med Univ, Dept Interdisciplinary Dent, Powstancow Wlkp 72, PL-70111 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Pharmacol, Powstancow Wlkp 72, PL-70111 Szczecin, Poland
关键词
gingival overgrowth; drug-induced gingival overgrowth; gingiva; drug side effects; TISSUE GROWTH-FACTOR; CALCIUM-CHANNEL BLOCKERS; CYCLOSPORINE-A; CONNECTIVE-TISSUE; ANGIOTENSIN-II; CATHEPSIN-L; LYSYL OXIDASE; IMMUNOHISTOCHEMICAL ANALYSIS; RECEPTOR EXPRESSION; CELL-PROLIFERATION;
D O I
10.3390/ijms24065448
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drug-induced gingival overgrowth (DIGO) is one of the side effects produced by therapeutic agents, most commonly phenytoin, nifedipine and cyclosporin A. However, the precise mechanism of DIGO is not entirely understood. A literature search of the MEDLINE/PubMed databases was conducted to identify the mechanisms involved in DIGO. The available information suggests that the pathogenesis of DIGO is multifactorial, but common pathogenic sequelae of events emerge, i.e., sodium and calcium channel antagonism or disturbed intracellular handling of calcium, which finally lead to reductions in intracellular folic acid levels. Disturbed cellular functions, mainly in keratinocytes and fibroblasts, result in increased collagen and glycosaminoglycans accumulation in the extracellular matrix. Dysregulation of collagenase activity, as well as integrins and membrane receptors, are key mechanisms of reduced degradation or excessive synthesis of connective tissue components. This manuscript describes the cellular and molecular factors involved in the epithelial-mesenchymal transition and extracellular matrix remodeling triggered by agents producing DIGO.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] The role of phosphatase and tensin homolog in drug-induced gingival overgrowth
    Cetinkaya, B. O.
    Pamuk, F.
    Keles, G. C.
    Ayas, B.
    Ozfidan, G. K.
    Kayisli, U.
    Arik, N.
    Horton, H.
    JOURNAL OF PERIODONTAL RESEARCH, 2014, 49 (03) : 307 - 313
  • [22] Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis
    Brown, R. S.
    Arany, P. R.
    ORAL DISEASES, 2015, 21 (01) : E51 - E61
  • [23] Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database
    Bondon-Guitton, Emmanuelle
    Bagheri, Haleh
    Montastruc, Jean-Louis
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2012, 39 (06) : 513 - 518
  • [24] Connective tissue growth factor in drug-induced gingival overgrowth
    Uzel, MI
    Kantarci, A
    Hong, HH
    Uygur, C
    Sheff, MC
    Firatli, E
    Trackman, PC
    JOURNAL OF PERIODONTOLOGY, 2001, 72 (07) : 921 - 931
  • [25] CHROMOSOMAL PROTEIN-PHOSPHORYLATION IN DRUG-INDUCED GINGIVAL OVERGROWTH
    PHIPPS, L
    BUCHANAN, JA
    JOURNAL OF DENTAL RESEARCH, 1990, 69 : 332 - 332
  • [26] Drug-induced gingival overgrowth impeding oral tracheal intubation
    Khodadad-Hossaini, A.
    Farrell, K.
    Gonzalez, R. M.
    ANAESTHESIA REPORTS, 2022, 10 (01)
  • [27] TGF β1 in drug-induced gingival overgrowth:: activation or synthesis?
    Morgan, CL
    Robertson, H
    Thomason, JM
    Kirby, JA
    Taylor, JJ
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 236 - 236
  • [28] Use of an argon laser to treat drug-induced gingival overgrowth
    Matson, JS
    Blankenau, R
    Keene, JJ
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1998, 129 (01): : 78 - 83
  • [29] DRUG-INDUCED GINGIVAL OVERGROWTH: AN IN VITRO STUDY ON CYCLOSPORINE AND HUMAN GINGIVAL FIBROBLASTS
    Candotto, V
    Baj, A.
    Beltramini, G.
    Scarano, A.
    Palmieri, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (06): : 21 - 27
  • [30] DISPOSITION OF NIFEDIPINE IN PLASMA AND GINGIVAL CREVICULAR FLUID IN RELATION TO DRUG-INDUCED GINGIVAL OVERGROWTH
    ELLIS, JS
    SEYMOUR, RA
    MONKMAN, S
    IDLE, JR
    JOURNAL OF PERIODONTAL RESEARCH, 1993, 28 (05) : 373 - 378